Semaglutide Titration Science: Why Your Doctor Starts You Low
GLP-1 receptor desensitization, gastric emptying, and why a slower ramp equals a better outcome.
Full article coming soon. This post will go deep on the pharmacology behind slow GLP-1 agonist titration: delayed gastric emptying kinetics, enteric receptor density, and the trial evidence that justifies the 4-week-per-step template. Until then, see our titration walk-through for the practical side.
Short answer
Semaglutide's therapeutic effects (appetite suppression, glycemic control) and its side effects (nausea, vomiting, constipation) share the same upstream mechanism: GLP-1 receptor activation. Activating the receptor faster than the gut can adapt triggers severe gastric dysmotility. Slow titration lets the autonomic nervous system re-set around the new baseline before the dose goes up. The four-week step is a pragmatic compromise between acclimation time and the clinical need to reach the maintenance dose.